ReSPECT-LM: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (clinicaltrials.gov) - Jan 14, 2022 - P1; N=18; Recruiting; Sponsor: Plus Therapeutics; Not yet recruiting ➔ Recruiting; Trial completion date: Aug 2022 ➔ Dec 2022
Clinical • Enrollment open • Trial completion date • Oncology
|